Short chain fatty acids (SCFAs), mainly including acetate, propionate and butyrate, are produced by intestinal bacteria during the fermentation of partially digested and indigestible polysaccharides. SCFAs play an important role in regulating intestinal energy metabolism and maintaining the homeostasis of the intestinal environment and also play an important regulatory role in organs and tissues outside the gut. In recent years, many studies have shown that SCFAs can regulate inflammation and affect host health, and two main signaling mechanisms have also been identified: the activation of G-protein coupled receptors (GPCRs) and inhibition of histone deacetylase (HDAC). In addition, a growing body of evidence highlights the importance of every SCFA in influencing health maintenance and disease development. In this review, we summarized the recent advances concerning the biological properties of SCFAs and their signaling pathways in inflammation and body health. Hopefully, it can provide a systematic theoretical basis for the nutritional prevention and treatment of human diseases.
High-Protein Mulberry is a novel strain of mulberry. High-Protein Mulberry leaves (HPM) were the subject of this study, which aimed to investigate its efficacy and underlying mechanisms in modulating glucose and lipid metabolism. A six-week intervention using db/db mice was carried out to assess the effects of HPM on serum lipid levels, liver function, and insulin (INS) levels. qRT-PCR and Western Blotting were employed to measure key RNA and protein expressions in the PI3K/Akt and PPARα/CPT-1 pathways. UHPLC-MS and the Kjeldahl method were utilized to analyze the component content and total protein. Additionally, network pharmacology was employed to predict regulatory mechanism differences between HPM and Traditional Mulberry leaves. The results of the study revealed significant improvements in fasting blood glucose, glucose tolerance, and insulin resistance in mice treated with HPM. HPM notably reduced serum levels of total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and INS, while increasing high-density lipoprotein cholesterol (HDL-C) levels. The treatment also effectively mitigated liver fatty lesions, inflammatory infiltration, and islet atrophy. HPM activation of the PI3K/Akt/PPARα/CPT-1 pathway suggested its pivotal role in the regulation of glucose and lipid metabolism. With its rich composition and pharmacodynamic material basis, HPM displayed a greater number of targets associated with glucose and lipid metabolism pathways, underscoring the need for further research into its potential therapeutic applications.
Background/Objectives: Impaired glucose tolerance (IGT) is a prediabetic condition affecting over 600 million adults worldwide. Mulberry leaf (Morus alba L.) has shown antidiabetic potential, but whether adipose AMPKα1 is required for its effects remains unclear. This study aimed to determine whether mulberry leaf water extract (MLE) ameliorates IGT through adipose AMPKα1-mediated gut microbiota modulation and thermogenesis. Methods: Adipose-specific AMPKα1 knockout (AKO) mice and floxed controls (Flox) were fed a high-fat diet for 12 weeks to establish IGT, then treated with MLE or short-chain fatty acids (SCFAs) for 10 weeks. Metabolic parameters, gut microbiota (16S rRNA sequencing), fecal SCFAs, and AMPKα1/SIRT1/PGC-1α pathway expression were assessed. Results: In Flox mice, MLE and SCFAs significantly improved glucose tolerance, reduced serum lipids and hepatic steatosis, and enhanced brown adipose tissue activation and white adipose browning. These effects were accompanied by gut microbiota remodeling, elevated fecal acetate/propionate/butyrate, and upregulation of the AMPKα1/SIRT1/PGC-1α pathway. All these metabolic and microbiota benefits were abrogated in AKO mice, in which MLE failed to improve any parameter, with only minimal and functionally insignificant thermogenic gene/protein upregulation. Conclusions: Adipose AMPKα1 is essential for MLE to improve IGT via gut microbiota/SCFAs and thermogenesis. These findings identify adipose AMPKα1 as a molecular target for dietary intervention in prediabetes.
Purpose To investigate the relationship between the susceptibility to type 2 diabetes and gut microbiota and explore the potential mechanisms. Methods Thirty-two SPF SD rats were raised as the donor rats, and divided into control, type 2 diabetes mellitus (T2DM) and Un-mod groups. Feces were collected and prepared as fecal bacteria supernatant A (T2DM group), B (Un-mod group) and Con (control group). Another seventy-nine SPF SD rats were separated into normal saline (NS) and ABX groups. ABX and NS groups were given antibiotics solution and normal saline, respectively. And then, the ABX group were randomly separated into the ABX1 (4-weeks ordinary diet), ABX2 (4-weeks HFD and STZ ip), FMT-A (fecal microbiota A transplantation, 4-weeks HFD and STZ ip), FMT-B (fecal microbiota B transplantation, 4-weeks HFD and STZ ip) and FMT-Con (normal fecal microbiota transplantation, 4-weeks HFD and STZ ip) groups. The NS group were randomly divided into the NS1 (4-weeks ordinary diet) and NS2 (4-weeks HFD and STZ ip) groups. The short-chain fatty acids (SCFAs) in feces were detected by gas chromatography using 16S rRNA gene sequencing. G protein-coupled receptor 41 (GPR41) and GPR43 were detected by Western blot and quantitative real-time polymerase chain reaction. Results g__Ruminococcus_gnavus_group were increased obviously in the FMT-A group (vs ABX2 or FMT-B group). Blood glucose levels, serum insulin, total cholesterol levels, triglyceride levels, and low-density lipoprotein cholesterol levels were evidently increased in the FMT-A group than ABX1 or ABX2 group. It was found that both the FMT-A and FMT-B groups had evidently higher contents of acetic acid and butyric acid (vs ABX2 group). In both FMT-A and FMT-B groups, GPR41 protein expression and GPR43 mRNA and protein expression increased. Conclusions G__Ruminococcus_gnavus_group may cause T2DM susceptibility, and T2DM susceptible flora transplantation can evidently increase the susceptibility to T2DM. It is possible that gut microbiota-SCFAs-GPR41/GPR43 play a role in the development of T2DM. A new treatment strategies and methods may be to develop pharmaceutical treatments that reduce blood glucose by controlling gut microbiota.